Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 139

1.

Physical exercise and catecholamine reuptake inhibitors affect orienting behavior and social interaction in a rat model of attention-deficit/hyperactivity disorder.

Robinson AM, Eggleston RL, Bucci DJ.

Behav Neurosci. 2012 Dec;126(6):762-71. doi: 10.1037/a0030488. Epub 2012 Oct 15.

2.
3.

Voluntary physical exercise alters attentional orienting and social behavior in a rat model of attention-deficit/hyperactivity disorder.

Hopkins ME, Sharma M, Evans GC, Bucci DJ.

Behav Neurosci. 2009 Jun;123(3):599-606. doi: 10.1037/a0015632.

PMID:
19485566
4.

Effects of physical exercise on ADHD-like behavior in male and female adolescent spontaneously hypertensive rats.

Robinson AM, Hopkins ME, Bucci DJ.

Dev Psychobiol. 2011 May;53(4):383-90. doi: 10.1002/dev.20530. Epub 2011 Feb 8.

PMID:
21305542
5.

Performance on a strategy set shifting task during adolescence in a genetic model of attention deficit/hyperactivity disorder: methylphenidate vs. atomoxetine treatments.

Harvey RC, Jordan CJ, Tassin DH, Moody KR, Dwoskin LP, Kantak KM.

Behav Brain Res. 2013 May 1;244:38-47. doi: 10.1016/j.bbr.2013.01.027. Epub 2013 Jan 31.

6.

Physical exercise affects attentional orienting behavior through noradrenergic mechanisms.

Robinson AM, Buttolph T, Green JT, Bucci DJ.

Behav Neurosci. 2015 Jun;129(3):361-7. doi: 10.1037/bne0000054.

7.

Effects of methylphenidate on attentional set-shifting in a genetic model of attention-deficit/hyperactivity disorder.

Cao AH, Yu L, Wang YW, Wang JM, Yang LJ, Lei GF.

Behav Brain Funct. 2012 Feb 28;8(1):10. doi: 10.1186/1744-9081-8-10.

8.

Methylphenidate disrupts social play behavior in adolescent rats.

Vanderschuren LJ, Trezza V, Griffioen-Roose S, Schiepers OJ, Van Leeuwen N, De Vries TJ, Schoffelmeer AN.

Neuropsychopharmacology. 2008 Nov;33(12):2946-56. doi: 10.1038/npp.2008.10. Epub 2008 Feb 27. Erratum in: Neuropsychopharmacology. 2008 Nov;33(12):3021.

9.

Treadmill exercise and methylphenidate ameliorate symptoms of attention deficit/hyperactivity disorder through enhancing dopamine synthesis and brain-derived neurotrophic factor expression in spontaneous hypertensive rats.

Kim H, Heo HI, Kim DH, Ko IG, Lee SS, Kim SE, Kim BK, Kim TW, Ji ES, Kim JD, Shin MS, Choi YW, Kim CJ.

Neurosci Lett. 2011 Oct 17;504(1):35-9. doi: 10.1016/j.neulet.2011.08.052. Epub 2011 Aug 31.

PMID:
21907264
10.

Atomoxetine increases fronto-parietal functional MRI activation in attention-deficit/hyperactivity disorder: a pilot study.

Bush G, Holmes J, Shin LM, Surman C, Makris N, Mick E, Seidman LJ, Biederman J.

Psychiatry Res. 2013 Jan 30;211(1):88-91. doi: 10.1016/j.pscychresns.2012.09.004. Epub 2012 Nov 10.

11.

Effects of atomoxetine on locomotor activity and impulsivity in the spontaneously hypertensive rat.

Turner M, Wilding E, Cassidy E, Dommett EJ.

Behav Brain Res. 2013 Apr 15;243:28-37. doi: 10.1016/j.bbr.2012.12.025. Epub 2012 Dec 22.

PMID:
23266523
12.

Differential effects of methylphenidate and atomoxetine on attentional processes in children with ADHD: an event-related potential study using the Attention Network Test.

Kratz O, Studer P, Baack J, Malcherek S, Erbe K, Moll GH, Heinrich H.

Prog Neuropsychopharmacol Biol Psychiatry. 2012 Apr 27;37(1):81-9. doi: 10.1016/j.pnpbp.2011.12.008. Epub 2011 Dec 29.

PMID:
22227291
13.

Adolescent atomoxetine treatment in a rodent model of ADHD: effects on cocaine self-administration and dopamine transporters in frontostriatal regions.

Somkuwar SS, Jordan CJ, Kantak KM, Dwoskin LP.

Neuropsychopharmacology. 2013 Dec;38(13):2588-97. doi: 10.1038/npp.2013.163. Epub 2013 Jul 3.

14.

Effect of methylphenidate treatment during adolescence on norepinephrine transporter function in orbitofrontal cortex in a rat model of attention deficit hyperactivity disorder.

Somkuwar SS, Kantak KM, Dwoskin LP.

J Neurosci Methods. 2015 Aug 30;252:55-63. doi: 10.1016/j.jneumeth.2015.02.002. Epub 2015 Feb 11.

15.

Differential behavioral and neurochemical effects of cocaine after early exposure to methylphenidate in an animal model of attention deficit hyperactivity disorder.

Augustyniak PN, Kourrich S, Rezazadeh SM, Stewart J, Arvanitogiannis A.

Behav Brain Res. 2006 Feb 28;167(2):379-82. Epub 2005 Oct 24.

PMID:
16246436
16.

Rearing in an enriched environment attenuated hyperactivity and inattention in the Spontaneously Hypertensive Rats, an animal model of Attention-Deficit Hyperactivity Disorder.

Botanas CJ, Lee H, de la Peña JB, Dela Peña IJ, Woo T, Kim HJ, Han DH, Kim BN, Cheong JH.

Physiol Behav. 2016 Mar 1;155:30-7. doi: 10.1016/j.physbeh.2015.11.035. Epub 2015 Nov 30.

PMID:
26656767
17.

Atomoxetine-induced increases in monoamine release in the prefrontal cortex are similar in spontaneously hypertensive rats and Wistar-Kyoto rats.

Ago Y, Umehara M, Higashino K, Hasebe S, Fujita K, Takuma K, Matsuda T.

Neurochem Res. 2014 May;39(5):825-32. doi: 10.1007/s11064-014-1275-5. Epub 2014 Mar 15.

PMID:
24634253
18.

Prepuberal subchronic methylphenidate and atomoxetine induce different long-term effects on adult behaviour and forebrain dopamine, norepinephrine and serotonin in Naples high-excitability rats.

Ruocco LA, Carnevale UA, Treno C, Sadile AG, Melisi D, Arra C, Ibba M, Schirru C, Carboni E.

Behav Brain Res. 2010 Jun 26;210(1):99-106. doi: 10.1016/j.bbr.2010.02.020. Epub 2010 Feb 13.

PMID:
20156489
19.

The spontaneously hypertensive rat/Izm (SHR/Izm) shows attention deficit/hyperactivity disorder-like behaviors but without impulsive behavior: therapeutic implications of low-dose methylphenidate.

Kishikawa Y, Kawahara Y, Yamada M, Kaneko F, Kawahara H, Nishi A.

Behav Brain Res. 2014 Nov 1;274:235-42. doi: 10.1016/j.bbr.2014.08.026. Epub 2014 Aug 20.

PMID:
25151620
20.

Methylphenidate normalizes elevated dopamine transporter densities in an animal model of the attention-deficit/hyperactivity disorder combined type, but not to the same extent in one of the attention-deficit/hyperactivity disorder inattentive type.

Roessner V, Sagvolden T, Dasbanerjee T, Middleton FA, Faraone SV, Walaas SI, Becker A, Rothenberger A, Bock N.

Neuroscience. 2010 Jun 2;167(4):1183-91. doi: 10.1016/j.neuroscience.2010.02.073. Epub 2010 Mar 6.

PMID:
20211696

Supplemental Content

Support Center